Why Most Royalty Rate Negotiations Start From the Wrong Number
Most tech transfer royalty negotiations anchor on industry averages and gut feel. Here's why that produces bad deals and what to use instead.
A. Kovacs6 posts tagged licensing from Commercializing Science.
MTAs look like administrative paperwork, but buried clauses routinely strip universities and startups of the IP rights they need to commercialize research.
A. KovacsField-of-use restrictions in university license agreements promise focused commercialization but routinely strangle deal value and block better applications from reaching market.
A. KovacsExclusive licenses feel like wins for everyone at signing. Here's why they quietly kill commercialization, and what to structure instead.
A. KovacsOption agreements should de-risk early licensing deals, but most TTOs use them wrong. Here's what's broken and how to fix it.
A. KovacsMost university licensing deals collapse not because of bad science or bad intent, but because of preventable negotiation failures. Here's what actually goes wrong.
A. Kovacs